This international hub brings together the clinical and biomedical engineering fields and provides talented medical students and clinicians exposure to the world of biomedical engineering, the challenges doctors face in diagnosing and treating patients and how to potentially solve these issues with cutting edge engineering solutions.
Years Of Experience
What We Offer
During training workshops, participants will benefit from attending lectures and seminars by leading experts in both fields. All participants will take part in small-group activities with peers and seniors to ensure they develop team working and leadership skills ready for real life working. Research opportunities offered include internships, MSc projects, PhD and Post Doctoral positions.
The Clinician Engineer Hub allows medical students and clinicians fascinated by disease pathology to understand the current diagnostic and treatment gaps in the clinical field and design effective solutions based on solid engineering principles. It will be revolutionary for your career with the unique opportunity to receive mentorship across world renowned academic centres in the UK and abroad
Dr Neel Sharma
Founder and Director
BSc (Hons), MBChB, MSc, MRCP (UK), PhD
Queen Elizabeth Hospital Birmingham, United Kingdom
Neel is a clinician academic in the field of gastroenterology at Queen Elizabeth Hospital Birmingham. He diagnoses and treats disorders of the GI tract as well as undertakes clinical research as a Lecturer at the Institute of Immunology and Immunotherapy and Institute of Translational Medicine, University of Birmingham. He has gained clinical and research training in London, Hong Kong, Singapore, Japan, Boston, New York, Fontainebleau and Stockholm. He also serves as a member of the World Health Organisation’s (WHO) Global Health Workforce Network Education platform.
Dr. Ali K. Yetisen
Co-founder and Deputy Director
Imperial College London, United Kingdom
Ali K. Yetisen is a Senior Lecturer (Associate Professor) in the Department of Chemical Engineering at Imperial College London and researches medical tattoos, point-of-care diagnostics, biophotonics, wearable devices and personalised medicine. He was previously the Tosteson postdoctoral fellow at Harvard University and Massachusetts General Hospital. He holds a Ph.D. degree in Chemical Engineering and Biotechnology from the University of Cambridge. He also lectures at the Harvard-MIT Division of Health Sciences and Technology.
Dr K Banu Kose
Strategy Lead Asia
Mr Jeffrey Turner
Strategy Lead United Kingdom
Ms Liana Shvachiy
Strategy Lead Europe
Ms Salma Soussi
Strategy Lead Africa
Strategy Lead North America
Mr Faisal Nawaz
Strategy Lead Middle East
Strategy Lead Innovation
Social Media and Events Team
Social Media and Events Team
Social Media and Events Team
Director of Clinician Engineer Hub New York
Director of Clinician Engineer Hub London
Prof Khek Yu Ho
National University Hospital of Singapore
Prof Chak-sing Lau
The University of Hong Kong
Dr Mads Bergholt
King’s College London, United Kingdom
Dr. Mads Begholt is currently a Lecturer in Biophotonics at King’s College London and co founder of the Clinician Engineer Hub.
His research interests include biomedical optics and light-tissue interaction, linear/non-linear optical spectroscopy/imaging, advanced endoscopy and artificial intelligence in preclinical disease models and in patients to shed new light on disease onset and progression. He holds several commercialized patents in healthcare.
Dr Timothy Kassis
Massachusetts Institute of Technology (MIT)
Dr Marielle Vehmeijer-Heeman
Radboud University Medical Center
Dr Jeff Mailu
Guillermo U Ruiz Esparza
Dr. Guillermo Ulises Ruiz-Esparza is a Medical Doctor, BioNanotechnologist and Entrepreneur. As a Physician Scientist his research is mainly focused in the development of Molecular NanoSystems at the Harvard-MIT Division of Health Sciences and Technology and at the Division of Engineering in Medicine part of Brigham and Women’s Hospital and Harvard Medical School. He received his MD and PhD in Biotechnology and Nanotechnology from the Monterrey Institute of Technology and Higher Education-Houston Methodist Hospital Joint MD/PhD Program, later on he pursued his Postdoctoral training in Biodesign as well as in Smart Bio and Nanomaterials at Harvard University, Massachusetts Institute of Technology (MIT) and Brigham and Women’s Hospital. He is a pioneer in the field of cardiovascular nanomedicine, as his work was the first to achieve intravascular and site-specific nanoparticle-based delivery to a failing heart, enabling the current development of new nanotechnologies for delivering genetic material and drugs for the treatment of heart failure.
University College London
Sara is a lecturer (Assistant Professor) in Wearable Technologies at University College London. She received a PhD from Ecole Polytechnique Federale de Lausanne (EPFL) in 2015 and has been with the Dept. of Electrical and Electronic Engineering, Imperial College as a Junior Research Fellow during Apr 2015 to Oct 2018. Her research interests include analogue/mixed-signal IC design and the monolithic integration of biosensors with microelectronics (Lab-on-Chip). She applies the developed tools and techniques in creating new wearable and implantable technologies for quantitative analysis of health conditions.
Prof Felise B Milan
Albert Einstein College of Medicine
Pia graduated from UNSW Computer Science Engineering (CSE) in 1995 and got her first big opportunity to create change in this area when she was made Chair of the Diversity and Inclusion Council at Ericsson in 2013. As Ericsson’s Diversity Lead, she introduced a leadership support structure to promote women in leadership in Ericsson’s key discipline areas. She also mentored young female employees who had chosen to pursue careers in engineering and telecommunications. She currently serves as Chair of the CSE Industry Advisory Board
Henry Ford West Bloomfield Hospital
Prof Marcy Zenobi Wong
Marcy Zenobi-Wong’s main research focus is cartilage engineering and regeneration: the success of cell-based therapies for tissue repair is dependent on our ability to reliably control the growth and differentiation of stem cells used in the treatment.
The interaction of cells with the extracellular environment can have a potent influence on cell fate. The nature of biomaterials (composition, charge and stiffness), ligand and growth factor availability, oxygen tension and the presence of mechanical and electrical signals can potently induce the desired morphology, cytoskeletal architecture and biosynthetic activity. She engineers both 2D and 3D cellular systems to mimic different extracellular environments.
Dr John Ong
University of Cambridge
Mark Wehde is chair of the Mayo Clinic Division of Engineering, assistant professor of Biomedical Engineering in the Mayo Clinic College of Medicine and Science, fellow in the Mayo Clinic Academy of Educational Excellence, and associate lecturer for the University of Wisconsin MBA Consortium program. Mark is the executive leader of a team of managers, engineers, software developers, project managers, and technologists in multiple operating units providing development, implementation, and integration of innovative technology solutions across Mayo Clinic to create medical devices that help our healthcare teams better care for our patients.
Phanish is a business savvy entrepreneur with expertise in the healthcare technology space. Phanish founded Docplexus and established it as a leading enterprise in Indian healthcare and doctor networking space.
Phanish is an executionist and outcome oriented leader. He is passionate about art, design and its practical application in technology based solutions.
Dr Mecit Can Emre Simsekler
Dr. Simsekler obtained his Ph.D. in Engineering from the University of Cambridge. Currently, he is an Assistant Professor at the Department of Industrial and Systems Engineering at Khalifa University of Science and Technology, and an Honorary Research Associate at the UCL School of Management. In addition, he is a Visiting Scholar at Boston Children’s Hospital and Cleveland Clinic Abu Dhabi. His research focuses on healthcare operations and system design for patient safety, quality and efficiency. Leveraging engineering principles, he explores proactive approaches to manage operational failures and safety risks to drive transformational system innovation and improvement in healthcare.
Prof Izabela Naydenova
Technological University Dublin
Dr Lidan You
University of Toronto
Dr Nobuyoshi Takeshita
National Cancer Centre
Dr Nobuyoshi Takeshita is a surgeon in the Department of Colorectal Surgery/ NEXT medical device innovation center at NCC Japan.
He has generated many collaborations with med tech start ups, academics and clinicians in Japan and Singapore including surgical robots, neuro modulators, tissue engineering, cancer diagnostic tools and AI based systems for minimally invasive surgery.